 |
 |
 |
Search Issue:
Sai Parenteral's IPO is a mainboard IPO aggregating up to 408 crore 78 lakh 88 thousand 8 hundred ninety-six rupees. The issue consists of a fresh issue of 72,70,408 shares (aggregating up to 284 crore 99 lakh 99 thousand 9 hundred thirty-six rupees) and an offer for sale of 31,57,880 shares (aggregating up to 123 crore 78 lakh 88 thousand 9 hundred sixty rupees).
The IPO opened for subscription on 24 March 2026 and closes on 27 March 2026. The basis of allotment was finalised on 30 March 2026. The shares were listed on NSE and BSE on 2 April 2026.
The price band for the IPO is set at ₹372 to ₹392 per share. The minimum amount required for a retail investor is ₹14,896 (38 shares, 1 lot). The minimum amount required for an sHNI investor is ₹2,08,544 (532 shares, 14 lots).
The final allotment price for the Sai Parenteral's IPO was fixed at ₹392 per share. The shares successfully listed on the BSE at ₹405.00 per share (with a listing gain of 3.32%) and on the NSE at ₹400.00 per share (with a listing gain of 2.04%).
Arihant Capital Markets Ltd is the lead manager and Bigshare Services is the registrar of the IPO.
Refer to Sai Parenteral's RHP for more detailed information.
Sai Parenterals Share Price Analysis API (Live)
▼
₹515.00
-5.20 (-1.00%)
As of 01 Sep, 2026
Open
₹520.20
Day High - Low
₹524.05 - ₹514.30
Volume
57,040
52 Weeks High
₹706.00
on 02 Jul 2026
52 Weeks Low
₹400.00
on 02 Apr 2026
RSI (14)
37.7
50 DMA
561.38
200 DMA
-
Loading...
Sai Parenteral's IPO Details Listed
IPO Date
24 March 2026 to 27 March 2026The opening and closing dates during which investors can apply for the IPO.
Listing Date
2 April 2026The date when shares start trading on the stock exchanges.
Face Value
₹5 per shareThe nominal value of a security stated in the company books. Mainly used as the base for dividends and accounting
Price Band
₹372 to ₹392 per shareThe minimum and maximum price range within which investors can bid for IPO shares.
Lot Size
38 sharesThe minimum number of shares an investor must apply for in a single IPO application.
Allotment Price
₹392 per shareThe final price at which shares are allocated to investors after the bidding process closes.
Listing Price (NSE)
400.00The opening trade price of the stock on its first day on the exchange (National Stock Exchange)
Listing Gain (NSE)
2.04%The percentage change between the allotment price and the listing price on listing day at NSE
Listing Price (BSE)
405.00The opening trade price of the stock on its first day on the exchange (Bombay Stock Exchange).
Listing Gain (BSE)
3.32%The percentage change between the allotment price and the listing price on listing day at BSE
Issue Type
Book Built Issue The method used to price the IPO. In a Book Built Issue, the price is determined by investor demand within the price band.
Listing At
NSE, BSEThe stock exchange(s) where the company shares will be officially listed and traded.
IPO Issue Details
Issue Size
1,04,28,288 shares (₹4,08,78,88,896)Total number of shares multiplied by the issue price.
Issue (Sale Type)
Fresh issue and Offer for saleIndicates whether the IPO includes new shares (Fresh Issue), existing shares sold by promoters (OFS).
Fresh Issue
72,70,408 shares (₹2,84,99,99,936)New shares created and sold by the company. Proceeds go directly to the company for business use.
Offer for Sale
31,57,880 shares (₹1,23,78,88,960)Existing shares sold by promoters or investors. Proceeds go to the sellers, not the company.
Share Holding (Pre Issue)
3,69,08,823 sharesTotal number of shares outstanding before the IPO.
Share Holding (Post Issue)
4,41,79,231 sharesTotal number of shares outstanding after the fresh issue shares are added.
ISIN Number
INE0H9F01037A unique 12 character international code that identifies a specific security for trading and settlement.
BSE Scrip Code
544742A unique numeric code assigned by the Bombay Stock Exchange to identify a listed company.
NSE Symbol
SAIPARENTA unique ticker symbol assigned by the National Stock Exchange to identify a listed company.
The Sai Parenteral's IPO is a mainboard IPO with issue size 1,04,28,288 shares (aggregating up to 408 crore 78 lakh 88 thousand 8 hundred ninety-six rupees). The issue is priced at ₹372 to ₹392 per share and is a mix of a fresh issue of 72,70,408 shares (aggregating up to 284 crore 99 lakh 99 thousand 9 hundred thirty-six rupees) and an offer for sale of 31,57,880 shares (aggregating up to 123 crore 78 lakh 88 thousand 9 hundred sixty rupees).
Sai Parenterals IPO Lot Size & Required Amount
Sai Parenterals IPO has set a price band of per share and lot size is of shares.
Retail investors can bid for a minimum of 1 lot (38 shares), requiring minimum investment of ₹14,896,
and maximum upto 13 lots (494 shares), requiring maximum investment of ₹1,93,648.
Small HNI investors can bid for a minimum of 14 lots (532 shares), requiring an investment of ₹2,08,544,
small hni (sHNI) investors can bid for a maximum of 67 lots (2546 shares), requiring an investment of ₹9,98,032 and big hni (bHNI) investors can bid for a minimum of 68 Lots (2584 shares), requiring an investment of ₹10,12,928.
Calculated at the cut-off price ₹ per share (the upper end of the price band).
Number of Shares Per Lot = Shares
| Application | Lot(s) | Shares | Amount |
|---|---|---|---|
|
Retail (Min) Minimum investment required for Retail Individual Investors (RII). |
1 | 38 | ₹14,896 |
|
Retail (Max) Maximum investment allowed for Retail Individual Investors (Must be under ₹2 Lakhs). |
13 | 494 | ₹1,93,648 |
|
S-HNI (Min) Minimum investment for Small High Net-worth Individuals (sHNI) (Must be above ₹2 Lakhs). |
14 | 532 | ₹2,08,544 |
|
S-HNI (Max) Maximum investment for Small High Net-worth Individuals (sHNI) (Must be up to ₹10 Lakhs). |
67 | 2546 | ₹9,98,032 |
|
B-HNI (Min) Minimum investment for Big High Net-worth Individuals (bHNI) (Must be above ₹10 Lakhs). |
68 | 2584 | ₹10,12,928 |
IPO Reservation
Sai Parenteral's IPO offers total 1,04,28,288 shares (100.00%) . Out of which 52,14,144 shares (50.00%) allocated to QIB, 20,85,659 shares (20.00%) allocated to QIB (Ex- Anchor), 15,64,243 shares (15.00%) allocated to NII and 31,28,485 shares (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
|
QIB Shares Offered
Qualified Institutional Buyers (e.g., mutual funds, banks). |
52,14,144 shares (50.00%) |
|
-
QIB (Anchor Investor)
A portion of QIB shares reserved specifically for anchor investors. |
31,28,485 shares (30.00%) |
|
-
QIB (Ex. Anchor)
Remaining QIB shares after anchor investor allocation. |
20,85,659 shares (20.00%) |
|
NII (HNI) Shares Offered
Non-Institutional Investors, also known as High Net-worth Individuals. |
15,64,243 shares (15.00%) |
|
-
bNII (bids > ₹10L)
Big HNI category for applications above ₹10 Lakhs. |
10,42,829 shares (10.00%) |
|
-
sNII (bids < ₹10L)
Small HNI category for applications between ₹2 Lakh and ₹10 Lakh. |
5,21,414 shares (5.00%) |
| Total Shares Offered | 1,04,28,288 shares (100.00%) |
IPO Anchor Investors
Sai Parenteral's IPO raises ₹122.64 crore from anchor investors. Sai Parenteral's IPO anchor bid date was 23 March 2026.
💼 Anchor Investors Allocation Letter (PDF)Bid Date
The date on which anchor investors can bid for the shares.
23 March 2026
Shares Offered
Total number of shares allocated specifically to anchor investors.
31,28,485 shares
Anchor Portion (₹ Cr.)
Total value of the shares allocated to anchor investors in crores.
122.64
Anchor lock-in period end date for 50% shares (30 Days)
Date when 50% of the anchor investor shares become eligible for open market trading.
Tuesday, 28 April 2026
Anchor lock-in period end date for rest 50% shares (90 Days)
Saturday, 27 June 2026
Sai Parenterals Financials (Restated Consolidated)
Annual Performance (31 Mar 25 vs 31 Mar 24)
Sai Parenterals Financials (Restated Consolidated)'s Assets increased by 1.6%, Revenue increased by 5.5%, Profit After Tax increased by 71.4%, EBITDA increased by 24.4%, Net Worth increased by 25.4%, Total Borrowing dropped by 20.9%, Reserves & Surplus increased by 31.1% compared to the previous financial year.
Assets
▲ 1.6%
(4.29)
Revenue
▲ 5.5%
(8.56)
Profit After Tax
▲ 71.4%
(6.01)
EBITDA
▲ 24.4%
(7.74)
Net Worth
▲ 25.4%
(19.38)
Total Borrowing
▼ 20.9%
(-24.84)
Reserves & Surplus
▲ 31.1%
(19.06)
Previous Financial Year Growth (31 Mar 24 vs 31 Mar 23)
Comparing 31 Mar 24 with 31 Mar 23, Assets increased by 100.1%, Revenue increased by 59.9%, Profit After Tax increased by 92.2%, EBITDA increased by 79.7%, Net Worth increased by 142.6%, Total Borrowing increased by 73.3%, Reserves & Surplus increased by 151.8%.
Assets (Prev Yr)
▲ 100.1%
(134.14)
Revenue (Prev Yr)
▲ 59.9%
(58.15)
Profit After Tax (Prev Yr)
▲ 92.2%
(4.04)
EBITDA (Prev Yr)
▲ 79.7%
(14.06)
Net Worth (Prev Yr)
▲ 142.6%
(44.91)
Total Borrowing (Prev Yr)
▲ 73.3%
(50.24)
Reserves & Surplus (Prev Yr)
▲ 151.8%
(36.96)
2-Year Performance Change (31 Mar 23 To 31 Mar 25)
Between 31 Mar 25 and 31 Mar 23, Assets increased by 103.3%, Revenue increased by 68.8%, Profit After Tax increased by 229.5%, EBITDA increased by 123.6%, Net Worth increased by 204.2%, Total Borrowing increased by 37.1%, Reserves & Surplus increased by 230.2%.
Assets (2-Yr Change)
▲ 103.3%
(138.43)
Revenue (2-Yr Change)
▲ 68.8%
(66.71)
Profit After Tax (2-Yr Change)
▲ 229.5%
(10.05)
EBITDA (2-Yr Change)
▲ 123.6%
(21.8)
Net Worth (2-Yr Change)
▲ 204.2%
(64.29)
Total Borrowing (2-Yr Change)
▲ 37.1%
(25.4)
Reserves & Surplus (2-Yr Change)
▲ 230.2%
(56.02)
| 30 Sep 25 In Cr. | 31 Mar 25 In Cr. | 31 Mar 24 In Cr. | 31 Mar 23 In Cr. | |
|---|---|---|---|---|
| Assets | 376.24 | 272.39 | 268.1 | 133.96 |
| Revenue | 89.43 | 163.74 | 155.18 | 97.03 |
| Profit After Tax | 7.76 | 14.43 | 8.42 | 4.38 |
| EBITDA | 16.24 | 39.44 | 31.7 | 17.64 |
| Net Worth | 209.37 | 95.78 | 76.4 | 31.49 |
| Total Borrowing | 76.07 | 93.95 | 118.79 | 68.55 |
| Reserves & Surplus | 188.84 | 80.36 | 61.3 | 24.34 |
Financial Performance Indicator (FPI)
| FPI | 30 Sep 2025 | 31 Mar 2025 |
|---|---|---|
ROE Return on Equity (ROE) is a measure of financial performance... | 5.13% | 16.82% |
ROCE Return on Capital Employed indicates how efficiently a company uses its capital. | 9.28% | 28.92% |
RoNW RoNW (Return on Net Worth) is the percentage of profit earned relative to the company's net worth and reflects overall profitability for shareholders. | 5.09% | 15.09% |
PAT Margin Profit After Tax as a percentage of revenue. Shows how much net profit is retained from every rupee of sales. | 8.93% | 8.88% |
EBITDA Margin EBITDA Margin indicates earnings before interest, tax, depreciation, and amortisation as a percentage of revenue; reflects core operating efficiency. | 18.68% | 24.18% |
Price to Book Value Compares the stock's market price to its book value per share. A higher ratio may indicate market premium. | 10.89 |
| Pre IPO | Post IPO | |
|---|---|---|
EPS Rs Earnings Per Share is a company's profit divided by outstanding shares. | 5.43 | |
P/E (x) Price to Earnings ratio is the ratio of a stock's market price to its earnings per share. Indicates how much investors pay per rupee of earnings. | 72.19 | |
Promoter Holding The percentage of total shares held by the company's founders or promoter group. | 61.23% | 51.2% |
Market Cap Total market value of a company's outstanding shares. | ₹1,731.83 crore | |
IPO Peer Comparison
| Company Name | P/E ratio | EPS (Basic) | EPS (Diluted) | NAV (per share) | RoNW (%) | P/BV |
|---|---|---|---|---|---|---|
| Gland Pharma | 44.71(Gland) | 42.40(Gland) | 42.40(Gland) | 555.41(Gland) | 7.63(Gland) | 2.87(Gland) |
| Senores Pharmaceuticals | 64.30(Senores) | 16.12(Senores) | 16.12(Senores) | 176.37(Senores) | 7.18(Senores) | 3.24(Senores) |
| Innova Captab | 32.45(Innova) | 22.41(Innova) | 22.41(Innova) | 167.66(Innova) | 13.37(Innova) | 5.26(Innova) |
| Sai Life Sciences | 107.70(Sai) | 8.83(Sai) | 8.61(Sai) | 102.12(Sai) | 7.99(Sai) | 7.45(Sai) |
| Sai Parenteral's | (Sai) | 5.43(Sai) | 5.43(Sai) | 35.98(Sai) | 15.09(Sai) | (Sai) |
IPO Subscription Status
Loading Latest IPO Data...
Sai Parenterals IPO Lead Manager(s)
- Arihant Capital Markets Ltd